Home › Companies › BICYCLE THERAPEUTICS PLC › 2023-2024
Compiled from SEC Form N-PX filings and BICYCLE THERAPEUTICS PLC’s Form 8-K, filed May 16, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 16, 2024: 11 items on BICYCLE THERAPEUTICS PLC’s Form 8-K, filed May 16, 2024: 11 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore BICYCLE THERAPEUTICS PLC in the interactive database Compare manager voting policies
These tallies are BICYCLE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 16, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. To re-elect as a director Kevin Lee | 36,413,260 | 977,286 | 7,561 | -- | -- | 97% | Not verified | — |
| 2. To re-elect as a director Jose-Carlos Gutierrez-Ramos | 35,019,069 | 2,371,385 | 7,653 | -- | -- | 94% | Not verified | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement | 36,186,115 | 1,202,477 | 9,515 | -- | -- | 97% | Not verified | — |
| 4. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S | 37,376,526 | 14,076 | 7,505 | -- | -- | 99.9% | Not verified | — |
| 5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K | 37,376,531 | 14,071 | 7,505 | -- | -- | 99.9% | Not verified | — |
| 6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K | 37,376,455 | 14,150 | 7,502 | -- | -- | 99.9% | Not verified | — |
| 7. To receive and adopt the Company's U.K | 36,494,043 | 896,166 | 7,898 | -- | -- | 98% | Not verified | — |
| 8. To approve the directors' remuneration report for the year ended December 31, 2023 | 36,200,790 | 1,188,057 | 9,260 | -- | -- | 97% | Not verified | — |
| 9. To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000 | 33,241,556 | 4,146,578 | 9,973 | -- | -- | 89% | Not verified | — |
| 10. To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K | 32,350,797 | 4,154,715 | 892,595 | -- | -- | 89% | Not verified | — |
| 11. To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association | 37,371,711 | 15,138 | 11,258 | -- | -- | 99.9% | Not verified | — |
Source: BICYCLE THERAPEUTICS PLC, Form 8-K, filed with the SEC on May 16, 2024 — read the filing on EDGAR.
Each item below shows how the 99 asset managers that disclosed a BICYCLE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BICYCLE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Ordinary Resolutions To re-elect as a director Kevin Lee, who retires in accordance with the Articles of Association
BICYCLE THERAPEUTICS PLC’s own tally for this item (“1. To re-elect as a director Kevin Lee”): 36,413,260 for, 977,286 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 1,418,238 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director Jose-Carlos Gutierrez-Ramos, who retires in accordance with the Articles of Association
BICYCLE THERAPEUTICS PLC’s own tally for this item (“2. To re-elect as a director Jose-Carlos Gutierrez-Ramos”): 35,019,069 for, 2,371,385 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 1,418,109 for, 129 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 0 | 129 | 0 | 0 | Against |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To adopt new articles of association, which are set forth in Annex B to the proxy statement
BICYCLE THERAPEUTICS PLC’s own tally for this item (“11. To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association”): 37,371,711 for, 15,138 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 1,418,238 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: Special Resolutions To empower the Board of Directors to allot equity securities for cash up to a maximum aggregate nominal amount of pounds1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply
BICYCLE THERAPEUTICS PLC’s own tally for this item (“10. To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K”): 32,350,797 for, 4,154,715 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 325,779 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 26,773 | 2,588 | 0 | 0 | Mixed |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 0 | 17,277 | 0 | 0 | Against |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 0 | 16,128 | 0 | 0 | Against |
| Listed Funds Trust | 0 | 14,396 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 12,512 | 0 | 0 | Against |
| DWS | 0 | 8,070 | 0 | 0 | Against |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 5,774 | 0 | 0 | Against |
| Equitable | 0 | 4,560 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 2,600 | 0 | 0 | Against |
| ProShares | 0 | 2,481 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 0 | 129 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 126 | 0 | 0 | Against |
Fund voting reports, all 20 managers: 1,005,818 for, 412,420 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 1,160,315 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,160,315 for.
Combines 6 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: To authorize the Board of Directors to allot shares or to grant rights to subscribe for or convert any security into shares up to a maximum aggregate nominal amount of pounds1,000,000
BICYCLE THERAPEUTICS PLC’s own tally for this item (“9. To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000”): 33,241,556 for, 4,146,578 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 325,779 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 26,773 | 2,588 | 0 | 0 | Mixed |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 0 | 17,277 | 0 | 0 | Against |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 0 | 16,128 | 0 | 0 | Against |
| Listed Funds Trust | 0 | 14,396 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 12,512 | 0 | 0 | Against |
| DWS | 0 | 8,070 | 0 | 0 | Against |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 5,774 | 0 | 0 | Against |
| Equitable | 0 | 4,560 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 2,600 | 0 | 0 | Against |
| ProShares | 0 | 2,481 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 0 | 129 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 126 | 0 | 0 | Against |
Fund voting reports, all 20 managers: 1,005,818 for, 412,420 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 1,160,315 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,160,315 for.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report")
The 20 asset managers below reported 1,418,238 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement
BICYCLE THERAPEUTICS PLC’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement”): 36,186,115 for, 1,202,477 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Fund voting reports, all 20 managers: 1,418,238 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 6,437,592 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 3,441,487 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 1,902,346 | 0 | 0 | 0 | For |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,545,026 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,413,513 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 1,160,315 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,004,535 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 948,157 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 883,105 | 0 | 0 | Against |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 822,945 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 800,000 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 765,757 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 408,201 | 0 | 0 | 0 | For |
| T. Rowe Price | 401,481 | 0 | 0 | 0 | For |
| Verition Fund Management LLC | 338,792 | 0 | 0 | 0 | For |
| PLATINUM INVESTMENT MANAGEMENT LTD | 316,165 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 190,200 | 0 | 0 | 0 | For |
| Allianz | 0 | 184,645 | 0 | 0 | Against |
| KENNEDY CAPITAL MANAGEMENT LLC | 174,115 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 140,800 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 121,102 | 0 | 0 | 0 | For |
| HighVista Strategies LLC | 102,289 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 89,668 | 0 | 0 | Against |
| Renaissance | 82,725 | 0 | 0 | 0 | For |
| COMERICA BANK | 78,770 | 0 | 0 | 0 | For |
Institutional-manager reports, all 81 managers: 22,988,957 for, 1,157,418 against, 7,200 withheld, 10 not voted. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve our directors' remuneration report for the year ended December 31, 2023 (the "directors' remuneration report"), which is set forth as Annex A to the proxy statement
BICYCLE THERAPEUTICS PLC’s own tally for this item (“8. To approve the directors' remuneration report for the year ended December 31, 2023”): 36,200,790 for, 1,188,057 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Fund voting reports, all 20 managers: 1,418,238 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 6,437,592 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 3,441,487 | 0 | 0 | 0 | For |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,545,026 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,413,513 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 140,800 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 121,102 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 30,450 | 0 | 0 | 0 | For |
| WOODSTOCK CORP | 24,981 | 0 | 0 | 0 | For |
| Twelve Points Wealth Management LLC | 0 | 0 | 0 | 7,200 | Withhold |
| Natixis | 6,067 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 4,299 | 0 | 0 | 0 | For |
| DAVENPORT & Co LLC | 3,000 | 0 | 0 | 0 | For |
| Lighthouse Investment Partners, LLC | 2,315 | 0 | 0 | 0 | For |
| FIRST MANHATTAN CO. LLC. | 2,200 | 0 | 0 | 0 | For |
| ADVISOR PARTNERS II, LLC | 1,381 | 0 | 0 | 0 | For |
| Atom Investors LP | 984 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 907 | 0 | 0 | 0 | For |
| Orion Portfolio Solutions, LLC | 907 | 0 | 0 | 0 | For |
| Pinnacle Wealth Management Advisory Group, LLC | 870 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 333 | 0 | 0 | 0 | For |
| GAMMA Investing LLC | 316 | 0 | 0 | 0 | For |
| US BANK NATIONAL ASSOCIATION | 300 | 0 | 0 | 0 | For |
| Centiva Capital, LP | 173 | 0 | 0 | 0 | For |
| TRUIST FINANCIAL CORP | 103 | 0 | 0 | 0 | For |
| Sonora Investment Management Group, LLC | 100 | 0 | 0 | 0 | For |
Institutional-manager reports, all 28 managers: 13,179,289 for, 7,200 withheld. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2024
The 20 asset managers below reported 1,418,238 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders
BICYCLE THERAPEUTICS PLC’s own tally for this item (“5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K”): 37,376,531 for, 14,071 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 1,418,238 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit Committee to determine our U.K. statutory 31,2024 auditors' remuneration for the year ending December 31, 2024
BICYCLE THERAPEUTICS PLC’s own tally for this item (“6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K”): 37,376,455 for, 14,150 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 808,119 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 389,646 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,779 | 0 | 0 | 0 | For |
| State Street | 29,361 | 0 | 0 | 0 | For |
| Fidelity | 17,277 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| DWS | 8,070 | 0 | 0 | 0 | For |
| Morgan Stanley | 7,920 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 5,774 | 0 | 0 | 0 | For |
| Equitable | 4,560 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 2,600 | 0 | 0 | 0 | For |
| ProShares | 2,481 | 0 | 0 | 0 | For |
| Invesco | 129 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 126 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2024
BICYCLE THERAPEUTICS PLC’s own tally for this item (“6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K”): 37,376,455 for, 14,150 against, per its Form 8-K filed May 16, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 7 asset managers below reported 610,119 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOR FUNDS | 484,785 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 60,000 | 0 | 0 | 0 | For |
| Harbor Funds II | 19,236 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,364 | 0 | 0 | 0 | For |
| John Hancock | 16,128 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,512 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 1,094 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,043,486 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | HARBOR FUNDS | 1.61% |
| 2 | BlackRock | 1.30% |
| 3 | T. Rowe Price | 1.08% |
| 4 | MUTUAL FUND SERIES TRUST | 0.20% |
| 5 | State Street | 0.10% |
| 6 | Harbor Funds II | 0.06% |
| 7 | Fidelity | 0.06% |
| 8 | Harbor ETF Trust | 0.05% |
| 9 | John Hancock | 0.05% |
| 10 | Listed Funds Trust | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 21.43% |
| 2 | Deep Track Capital, LP | 11.46% |
| 3 | Paradigm Biocapital Advisors LP | 6.33% |
| 4 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 5.14% |
| 5 | ARMISTICE CAPITAL, LLC | 4.70% |
| 6 | First Light Asset Management, LLC | 3.86% |
| 7 | Polar Capital Holdings Plc | 3.34% |
| 8 | Candriam S.C.A. | 3.16% |
| 9 | BNP Paribas Asset Management Holding S.A. | 2.94% |
| 10 | SUVRETTA CAPITAL MANAGEMENT, LLC | 2.74% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Paradigm BioCapital Advisors LP | 12.34% | 13G |
| Morgan Stanley | 2.74% | 13F |
| T. Rowe Price | 1.34% | 13F |
| Point72 | 1.14% | 13F |
| BlackRock | 0.94% | 13F |
| Renaissance Technologies | 0.55% | 13F |
| Citadel Advisors | 0.26% | 13F |
| Two Sigma | 0.10% | 13F |
| State Street | 0.09% | 13F |
| Geode Capital | 0.07% | 13F |
Percentages above are of 30,043,486 shares outstanding, as reported by BICYCLE THERAPEUTICS PLC on its Form 10-Q dated May 1, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BICYCLE THERAPEUTICS PLC’s 10-Q dated May 1, 2023. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At BICYCLE THERAPEUTICS PLC's shareholder meeting held May 16, 2024, in the 2023-2024 proxy season, 99 asset managers reported how they voted in their SEC Form N-PX filings, covering 449 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of our named executive officers, as disclosed… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BICYCLE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 16, 2024.
BICYCLE THERAPEUTICS PLC proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.